Literature DB >> 3675199

Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis.

M H Shiu1, E Moore, M Sanders, A Huvos, B Freedman, J Goodbold, S Chaiyaphruk, R Wesdorp, M F Brennan.   

Abstract

The therapeutic value of extensive gastric resection and regional lymphadenectomy in the curative treatment of gastric adenocarcinoma is controversial. We undertook a retrospective study of 210 patients treated with curative intent from 1960 to 1980. A multivariate survival analysis using the Cox model revealed five significant variables predictive of death from gastric cancer--two inherent pathologic factors: (1) nonpyloric site and (2) metastases in more than three lymph nodes, and three treatment factors that could often be controlled by the surgeon: (3) microscopic positive gastric resection margin, (4) inadequate lymphadenectomy, and (5) total gastrectomy. These observations reaffirm the value of wide gastric resection and adequate lymphadenectomy but argue against a general policy of elective total gastrectomy in the curative treatment of gastric carcinoma.

Entities:  

Mesh:

Year:  1987        PMID: 3675199     DOI: 10.1001/archsurg.1987.01400230135024

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  40 in total

1.  Isolated resectable pancreatic metastasis 10 years post gastrectomy.

Authors:  A E Brannigan; M J Kerin; J C O'Keane; G P McEntee
Journal:  Ir J Med Sci       Date:  2000 Jul-Sep       Impact factor: 1.568

2.  Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients.

Authors:  M S Karpeh; L Leon; D Klimstra; M F Brennan
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

3.  Adenocarcinoma of the stomach: a review of 35 years and 1,710 cases.

Authors:  J R Breaux; W Bringaze; C Chappuis; I Cohn
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

Review 4.  Current role of surgical therapy in gastric cancer.

Authors:  Ryan Swan; Thomas J Miner
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

5.  How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience.

Authors:  Ehab El Hanafy; Ayman El Nakeeb; Helmy Ezzat; Emad Hamdy; Ehab Atif; Tharwat Kandil; Amgad Fouad; Mohamed Abdel Wahab; Ahmed Monier
Journal:  World J Gastrointest Surg       Date:  2016-06-27

6.  Differences in gastric cancer survival between the U.S. and China.

Authors:  Vivian E Strong; Ai-Wen Wu; Luke V Selby; Mithat Gonen; Meier Hsu; Kyo Young Song; Cho Hyun Park; Daniel G Coit; Jia-Fu Ji; Murray F Brennan
Journal:  J Surg Oncol       Date:  2015-07-14       Impact factor: 3.454

7.  Perspectives of surgery and multimodality treatment in gastric carcinoma.

Authors:  H J Meyer; J Jähne; H Wilke
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study.

Authors:  J R Siewert; K Böttcher; H J Stein; J D Roder
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

9.  Cancer of the stomach: a review of two hospitals in Korea and Japan.

Authors:  Y J Mok; B W Koo; C W Whang; S M Kim; K Maruyama; M Sasako; T Kinoshita
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

10.  Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma.

Authors:  J Jaehne; C Urmacher; H T Thaler; H Friedlander-Klar; C Cordon-Cardo; H J Meyer
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.